Tokyo-based Cykinso, which develops and sells Mykinso – a test kit for intestinal flora, has announced that it secured 270 million yen ($2.3 million ) from the Regional Health Care Industry Support Fund and other investors in its seed round.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
